Competing interests
SYC: consulting fees from Allergan, Bayer, Novartis, Roche, and Théa; CF: consulting fees from Allergan, Bayer, and Novartis; SB: consulting fees from Bayer, Allergan/AbbVie, Horus Pharma, Novartis, and Roche; HO: consulting fees from Allergan, Bayer, Novartis, Roche, and Théa; LK: consulting fees from Allergan/AbbVie, Alcon, Bayer, Krystal Biotech, Novartis, Regeneron, and Théa; MW: member of the French advisory board for Bayer. MD and FC declare no competing interests.